The Facebook founder said the risks of allowing Donald Trump to continue using his services are ‘too great’
‘The impact of the festive period cannot yet be determined’, says European Regional Director
Abigail Mamo was asked to react to the news that further measures may be introduced in the coming days
Health Minister Chris Fearne delivered an update about the Moderna COVID vaccine
Support levels will no longer be calculated based on NACE category
England will remain on lockdown until at least mid-February
The vaccine was developed by the state-controlled firm Sinopharm
The re-opening of bars has been set back by another month
The Prime Minister referred to the approval of the Oxford-AstraZeneca vaccine as "a trump for British science"
Malta registers its first case of the hyper-infectious COVID-19 strain
UK regulators have approved the coronavirus vaccine developed by the University of Oxford.
A ‘minor logistical issue’ meant the rescheduling of several deliveries
Around 1,000 companies obtained permission to implement these changes, of which 200 are still participating
‘We caution against a possible K-shaped recovery, where different parts of the economy would recover at different rates’
SME Chamber CEO hopes sector has a speedy recovery as people look to make up for a dull 2020
The Facebook founder said the risks of allowing Donald Trump to continue using his services are ‘too great’
‘The impact of the festive period cannot yet be determined’, says European Regional Director
Abigail Mamo was asked to react to the news that further measures may be introduced in the coming days
Health Minister Chris Fearne delivered an update about the Moderna COVID vaccine
Support levels will no longer be calculated based on NACE category
England will remain on lockdown until at least mid-February
The vaccine was developed by the state-controlled firm Sinopharm
The re-opening of bars has been set back by another month
The Prime Minister referred to the approval of the Oxford-AstraZeneca vaccine as "a trump for British science"
Malta registers its first case of the hyper-infectious COVID-19 strain
UK regulators have approved the coronavirus vaccine developed by the University of Oxford.
A ‘minor logistical issue’ meant the rescheduling of several deliveries
Around 1,000 companies obtained permission to implement these changes, of which 200 are still participating
‘We caution against a possible K-shaped recovery, where different parts of the economy would recover at different rates’
SME Chamber CEO hopes sector has a speedy recovery as people look to make up for a dull 2020